Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Supernus Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 239
- −8 vs. Q2 2023
- Shares held
- 57.0M
- +527.4K (+0.9%) vs. Q2 2023
- Total value
- $1.57B
- −$126.2M (−7.4%) vs. Q2 2023
- New holders
- 22
- 85 more added
- Sold out
- 30
- 94 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SUPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 334 | $2.80B |
| Q1 2026 | 328 | $3.01B |
| Q4 2025 | 333 | $2.84B |
| Q3 2025 | 310 | $2.76B |
| Q2 2025 | 295 | $1.87B |
| Q1 2025 | 295 | $1.94B |
| Q4 2024 | 294 | $2.15B |
| Q3 2024 | 273 | $1.87B |
| Q2 2024 | 245 | $1.56B |
| Q1 2024 | 251 | $1.93B |
| Q4 2023 | 245 | $1.65B |
| Q3 2023 | 239 | $1.57B |
| Q2 2023 | 249 | $1.72B |
| Q1 2023 | 259 | $2.01B |
| Q4 2022 | 264 | $1.99B |
| Q3 2022 | 244 | $1.88B |
| Q2 2022 | 225 | $1.58B |
| Q1 2022 | 230 | $1.75B |
| Q4 2021 | 235 | $1.61B |
| Q3 2021 | 224 | $1.45B |
| Q2 2021 | 226 | $1.67B |
| Q1 2021 | 224 | $1.40B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Supernus Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| S&T Bank | 215,578 | $5.94M | 1.15% | −5,665−2.6% | Reduced |
| Integral Health Asset Management, LLC | 220,000 | $6.07M | 0.86% | +145,000+193.3% | Added |
| Nuveen Asset Management, LLC | 230,592 | $6.36M | 0.00% | −57,714−20.0% | Reduced |
| SEI Investments Co | 267,274 | $7.37M | 0.01% | −1,451−0.5% | Reduced |
| Scout Investments, Inc. | 286,829 | $7.78M | 0.18% | −8,329−2.8% | Reduced |
| Norges Bank | 297,288 | $8.20M | 0.00% | −43,359−12.7% | Reduced |
| Principal Financial Group Inc | 303,780 | $8.38M | 0.01% | −13,816−4.4% | Reduced |
| Mutual of America Capital Management LLC | 346,115 | $9.54M | 0.12% | −1,770−0.5% | Reduced |
| Tributary Capital Management, LLC | 352,429 | $9.72M | 0.92% | +4,189+1.2% | Added |
| Bank of America Corp | 355,002 | $9.79M | 0.00% | +52,325+17.3% | Added |
| Citadel Advisors LLC | 375,826 | $10.4M | 0.01% | +286,839+322.3% | Added |
| Epoch Investment Partners, Inc. | 387,653 | $10.7M | 0.07% | −88,386−18.6% | Reduced |
| International Biotechnology Trust PLC | 426,500 | $11.8M | 3.96% | −97,000−18.5% | Reduced |
| Bank of New York Mellon Corp | 455,927 | $12.6M | 0.00% | −2,093−0.5% | Reduced |
| Price T Rowe Associates Inc | 477,380 | $13.2M | 0.00% | −35,624−6.9% | Reduced |
| Morgan Stanley | 528,579 | $14.6M | 0.00% | −27,319−4.9% | Reduced |
| Charles Schwab Investment Management Inc | 531,246 | $14.6M | 0.00% | −11,262−2.1% | Reduced |
| Rice Hall James & Associates, LLC | 544,468 | $15.0M | 0.95% | −10,325−1.9% | Reduced |
| Ameriprise Financial Inc | 569,019 | $15.7M | 0.01% | −26,206−4.4% | Reduced |
| Bellevue Group AG | 580,600 | $16.0M | 0.26% | −69,656−10.7% | Reduced |
| Invesco Ltd. | 682,691 | $18.8M | 0.01% | −64,791−8.7% | Reduced |
| Victory Capital Management Inc | 711,169 | $19.6M | 0.02% | +52,468+8.0% | Added |
| Northern Trust Corp | 734,150 | $20.2M | 0.00% | −1,438−0.2% | Reduced |
| Ashford Capital Management Inc | 916,747 | $25.3M | 3.72% | −9,364−1.0% | Reduced |
| Congress Asset Management Co | 917,164 | $25.3M | 0.22% | +147,105+19.1% | Added |
| Pictet Asset Management Holding SA | 920,552 | $25.4M | 0.03% | +920,552 | New |
| Geode Capital Management, LLC | 1,093,097 | $30.1M | 0.00% | +38,951+3.7% | Added |
| Aristotle Capital Boston, LLC | 1,187,981 | $32.8M | 1.06% | +26,034+2.2% | Added |
| GW&K Investment Management, LLC | 1,406,158 | $38.8M | 0.39% | +6,903+0.5% | Added |
| Renaissance Technologies LLC | 1,438,422 | $39.7M | 0.07% | −57,900−3.9% | Reduced |
| Polar Capital Holdings Plc | 1,654,470 | $45.6M | 0.34% | +150,000+10.0% | Added |
| Stephens Investment Management Group LLC | 1,704,698 | $47.0M | 0.77% | +3,983+0.2% | Added |
| Loomis Sayles & Co L P | 1,730,269 | $47.7M | 0.08% | +136,964+8.6% | Added |
| State Street Corp | 1,917,010 | $52.9M | 0.00% | +47,718+2.6% | Added |
| Dimensional Fund Advisors LP | 2,314,783 | $63.8M | 0.02% | −116,133−4.8% | Reduced |
| Macquarie Group Ltd | 2,750,856 | $75.8M | 0.10% | +247,398+9.9% | Added |
| Armistice Capital, LLC | 5,092,000 | $140.4M | 4.17% | +56,000+1.1% | Added |
| Vanguard Group Inc | 6,072,180 | $167.4M | 0.00% | +28,711+0.5% | Added |
| BlackRock Inc. | 10,179,905 | $280.7M | 0.01% | +219,482+2.2% | Added |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −59,318−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −53,200−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −52,192−100.0% | Sold out |
| Jackson Creek Investment Advisors LLC | 0 | $0 | 0.00% | −31,118−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −28,300−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −27,769−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −27,334−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −24,900−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −24,105−100.0% | Sold out |
| LSV Asset Management | 0 | $0 | 0.00% | −22,400−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −21,866−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −16,946−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −19,600−100.0% | Sold out |
| Capital Impact Advisors, LLC | 0 | $0 | 0.00% | −15,598−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −14,142−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −13,744−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −12,974−100.0% | Sold out |
| MQS Management LLC | 0 | $0 | 0.00% | −10,595−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −8,791−100.0% | Sold out |
| Mesirow Institutional Investment Management, Inc. | 0 | $0 | 0.00% | −8,165−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −7,958−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −7,409−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −7,406−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −6,668−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,331−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −520−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| EA Series Trust | – | – | – | – | Not filed |